Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novartis AG - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVS
New York
2834
www.novartis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novartis AG
Abcuro secures $200m as it eyes approval for rare muscle disease drug
- Feb 12th, 2025 6:40 pm
Sector Update: Health Care Stocks Fall in Late Afternoon Trading
- Feb 11th, 2025 8:56 pm
Top Midday Stories: Apple, Alibaba Shares Rise on AI Partnership News; Fidelity National Shares Fall After Q4 Revenue Miss
- Feb 11th, 2025 4:31 pm
Novartis signs agreement to acquire Anthos for $925m upfront
- Feb 11th, 2025 11:40 am
Novartis Strikes Up to $3.1 Billion Deal to Buy Anthos Therapeutics
- Feb 11th, 2025 11:32 am
Novartis pays $925M to reel in a startup it helped launch
- Feb 11th, 2025 10:00 am
Novartis buys Blackstone's Anthos for up to $3.1 billion
- Feb 11th, 2025 6:41 am
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
- Feb 11th, 2025 6:15 am
Is Novartis AG (NVS) The Best Annual Dividend Stock To Buy Now?
- Feb 10th, 2025 6:55 pm
Novartis and Dawn Health introduce breast cancer support app
- Feb 6th, 2025 6:06 pm
Why Novartis (NVS) is a Top Momentum Stock for the Long-Term
- Feb 6th, 2025 2:50 pm
Novartis Rises 5% Since Q4 Earnings: How Should You Play the Stock?
- Feb 6th, 2025 2:48 pm
Pfizer taps former Novartis exec to lead cancer drug push
- Feb 6th, 2025 7:45 am
Novartis AG (NVS): Among the Best Foreign Dividend Stocks to Invest In Now
- Feb 5th, 2025 3:13 pm
Here's Why Novartis (NVS) is a Strong Value Stock
- Feb 5th, 2025 2:40 pm
Radiopharmaceutical deals drive sector growth despite supply crisis
- Feb 5th, 2025 8:00 am
Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know
- Feb 4th, 2025 4:47 pm
2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond
- Feb 3rd, 2025 1:32 pm
Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ...
- Feb 1st, 2025 7:03 am
Novartis Pares Gains As Its Bread-And-Butter Drug Faces Looming Competition
- Jan 31st, 2025 9:08 pm
Scroll